Business Model (A)
IDRS identifies various products and progresses along the development path to create substantial value in the product. The products are licensed to partners for commercialization.
Business Model (B)
In this model, IDRS has successfully out-licensed all developed projects. Many of the top 10 pharmaceutical companies are our partners for these projects. The projects in pipeline are in early development stages